Germany invests €500M to combat Long COVID and Chronic Fatigue Syndrome

Germany invests €500M to combat Long COVID and Chronic Fatigue Syndrome

John Bailey
John Bailey•
• 2 Min.
A poster with a group of people standing in front of a windowed wall, with the words "Emerging Infectious Diseases" written across the top, and the people appearing to look up at the poster.

National Decade Against Post-Infectious Diseases Launched - Germany invests €500M to combat Long COVID and Chronic Fatigue Syndrome

The German government has launched a major research initiative to tackle post-infectious diseases like Long COVID and Chronic Fatigue Syndrome (CFS). Over the next decade, scientists will investigate causes, develop better diagnostic tools, and search for treatments. The project, backed by €500 million in federal funding, aims to improve understanding of illnesses that persist after infections.

The National Decade Against Post-Infectious Diseases brings together the Network of University Medicine (NUM), research institutions, and the Federal Ministry of Health. Their focus includes Long COVID and ME/CFS, a condition affecting an estimated 650,000 people in Germany after viral infections. Currently, no effective treatments exist for ME/CFS, which often overlaps with Long COVID symptoms.

The NAKO Health Study, a key part of the initiative, will examine how infections influence long-term health. Researchers hope to uncover mechanisms behind these diseases and create better ways to diagnose and treat them.

Patient advocacy group Long COVID Deutschland has pushed for greater public recognition of these conditions. Meanwhile, CDU/CSU research policy spokesperson Dr. Andreas Lenz stressed the importance of sustained research in an interview with Redaktionsnetzwerk Deutschland. He also warned that progress may take time, urging patience as scientists work toward solutions.

The €500 million funding will support long-term research into post-infectious illnesses. Scientists plan to study underlying causes, improve diagnostics, and develop treatments. The initiative marks a significant step in addressing conditions that affect thousands after infections.

Neueste Nachrichten